Acumen Pharmaceuticals, Inc.

ABOS Healthcare Biotechnology

In the quarter to June 2026, EPS grew 33.8%, free cash flow grew 43.2% and total debt rose 5.65%, each against the same quarter a year earlier.

1.69 0.02 +1.20%
Market cap
$120.8M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
0.56
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Total current assets
122.25 178.31 246.62 180.33 198.66 44.43 7.18
Total non-current assets
0.58 60.69 63.51 16.26 31.67 — 0.14
Total Assets
122.83 238.99 310.13 196.59 230.33 44.43 7.32
Total current liabilities
30.01 27.61 12.97 7.81 5.15 0.95 0.77
Total non-current liabilities
22.40 29.57 30.18 — — 62.07 17.98
Total liabilities
52.40 57.18 43.15 7.81 5.15 63.02 18.74
Common Equity (Total)
70.43 181.82 266.97 188.78 225.18 (18.59) (11.42)
Shareholders Equity (Total)
70.43 181.82 266.97 188.78 225.18 (18.59) (11.42)
Total Debt
31.16 29.42 29.90 0.11 — — —

Show all line items

In millions of $ except per-share values · columns are period end dates